Balance Sheet Dive: Traws Pharma Inc (TRAW)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

Kevin Freeman

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

After finishing at $1.09 in the prior trading day, Traws Pharma Inc (NASDAQ: TRAW) closed at $1.13, up 3.67%. In other words, the price has increased by $3.67 from its previous closing price. On the day, 90442.0 shares were traded. TRAW stock price reached its highest trading level at $1.13 during the session, while it also had its lowest trading level at $1.064.

Ratios:

Our goal is to gain a better understanding of TRAW by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.22 and its Current Ratio is at 1.22. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

. In the most recent recommendation for this company, H.C. Wainwright on December 03, 2025, initiated with a Buy rating and assigned the stock a target price of $8.

On March 01, 2022, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $7.

On May 18, 2021, Guggenheim started tracking the stock assigning a Buy rating and target price of $4.Guggenheim initiated its Buy rating on May 18, 2021, with a $4 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TRAW now has a Market Capitalization of 9029680 and an Enterprise Value of 2609679. As of this moment, Traws’s Price-to-Earnings (P/E) ratio for their current fiscal year is 0.05. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.17 while its Price-to-Book (P/B) ratio in mrq is 1.77. Its current Enterprise Value per Revenue stands at 0.917 whereas that against EBITDA is -0.166.

Stock Price History:

The Beta on a monthly basis for TRAW is 1.32, which has changed by -0.87427914 over the last 52 weeks, in comparison to a change of 0.17511821 over the same period for the S&P500. Over the past 52 weeks, TRAW has reached a high of $9.60, while it has fallen to a 52-week low of $0.97. The 50-Day Moving Average of the stock is -46.54%, while the 200-Day Moving Average is calculated to be -39.24%.

Shares Statistics:

The stock has traded on average 414.64K shares per day over the past 3-months and 620510 shares per day over the last 10 days, according to various share statistics. A total of 7.13M shares are outstanding, with a floating share count of 6.63M. Insiders hold about 17.01% of the company’s shares, while institutions hold 16.14% stake in the company. Shares short for TRAW as of 1765756800 were 175604 with a Short Ratio of 0.42, compared to 1763078400 on 74142. Therefore, it implies a Short% of Shares Outstanding of 175604 and a Short% of Float of 3.9300002000000003.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.